You can buy or sell FULC and other stocks, options, ETFs, and crypto commission-free!
Fulcrum Therapeutics, Inc. Common Stock, also called Fulcrum Therapeutics, is a clinical-stage biopharmaceutical company. Read More It develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
-$2.98 per share
Available Nov 14, Pre-Market